Absorption Kinetics – Definition & Clinical Relevance
Absorption kinetics describes how quickly and to what extent an active substance enters the bloodstream after administration. It is a core concept in pharmacokinetics.
Things worth knowing about "Absorption kinetics"
Absorption kinetics describes how quickly and to what extent an active substance enters the bloodstream after administration. It is a core concept in pharmacokinetics.
What is Absorption Kinetics?
Absorption kinetics is a branch of pharmacokinetics that deals with the time-dependent process by which a drug or active substance is taken up from the site of administration into the systemic bloodstream. It describes how fast and how completely a substance is absorbed after it has been taken orally, injected, or administered by any other route.
Understanding absorption kinetics is essential for drug development, determining dosing intervals, and planning clinical therapies effectively.
Key Concepts in Absorption Kinetics
Bioavailability
Bioavailability (F) refers to the fraction of an administered dose that reaches the systemic circulation in unchanged form. By definition, intravenous administration achieves 100% bioavailability. With oral administration, bioavailability can be significantly reduced by the first-pass effect in the liver.
Absorption Rate and Absorption Rate Constant
The speed of absorption is described by the absorption rate constant ka. A high value indicates rapid absorption, while a low value indicates slower uptake into the bloodstream.
Maximum Plasma Concentration (Cmax) and Time to Peak (tmax)
Two important parameters in absorption kinetics are:
- Cmax: The highest concentration of the drug measured in the blood plasma after administration.
- tmax: The time at which Cmax is reached, indicating how quickly the drug begins to take effect.
Kinetic Models of Absorption
First-Order Absorption
Most orally administered drugs follow first-order kinetics, meaning that the rate of absorption is proportional to the amount of drug remaining at the absorption site. As the concentration at the site decreases, so does the rate of absorption.
Zero-Order Absorption
Certain drug formulations, such as extended-release tablets or transdermal patches, release and absorb a constant amount of drug per unit of time. This is referred to as zero-order kinetics and results in more stable and consistent plasma levels over time.
Factors Influencing Absorption Kinetics
Many factors can affect the rate and extent of drug absorption:
- Route of administration: Intravenous (immediate effect), oral, subcutaneous, inhalation, transdermal, etc.
- Physicochemical properties of the drug: Lipophilicity, molecular size, degree of ionization, and solubility determine how well a substance can cross biological membranes.
- Gastrointestinal transit: Gastric emptying time, intestinal motility, stomach pH, and food intake significantly affect oral absorption.
- Dosage form: Tablets, capsules, solutions, and extended-release formulations differ in their drug release profiles.
- Blood flow at the absorption site: Higher blood flow increases removal of absorbed drug and facilitates further uptake.
- First-pass effect: Substances absorbed orally pass through the liver first, where they may be metabolized before reaching systemic circulation.
- Transporter proteins: Membrane transporters such as P-glycoprotein can either inhibit or promote drug absorption.
Clinical Relevance
Absorption kinetics has direct clinical implications:
- It determines the onset of drug action.
- It influences dosing intervals and the choice of drug formulation.
- It is critical for comparing generic drugs with original products in bioequivalence studies.
- In patients with altered gastrointestinal function, liver disease, or concurrent medication use, absorption kinetics may be modified, requiring dose adjustments.
Absorption Kinetics and Pharmacokinetic Models
In pharmacology, compartment models are used to mathematically describe absorption kinetics. The commonly applied one-compartment model assumes uniform drug distribution throughout the body after absorption. The two-compartment model additionally accounts for delayed distribution into peripheral tissues. These models help construct plasma concentration-time curves and optimize dosing regimens.
References
- Rowland, M. & Tozer, T.N. - Clinical Pharmacokinetics and Pharmacodynamics: Concepts and Applications. 4th Edition. Lippincott Williams & Wilkins, 2011.
- Shargel, L. & Yu, A.B.C. - Applied Biopharmaceutics & Pharmacokinetics. 7th Edition. McGraw-Hill Education, 2016.
- European Medicines Agency (EMA) - Guideline on the Investigation of Bioequivalence. CPMP/EWP/QWP/1401/98 Rev. 1, 2010. Available at: https://www.ema.europa.eu
Most purchased products
For your iron balance
Specially formulated for your iron balance with plant-based curry leaf iron, Lactoferrin CLN®, and natural Vitamin C from rose hips.
For your universal protection
As one of the most valuable proteins in the body, lactoferrin is a natural component of the immune system.
For Healthy Oral Flora & Dental Care
Formulated lozenges with Dentalac®, probiotic lactic acid bacteria, and Lactoferrin CLN®The latest entries
3 Posts in this encyclopedia categoryMagnetic resonance spectroscopy
Inositol phosphate
Most read entries
3 Posts in this encyclopedia categoryMagnesiumcarbonat
Calorie content
Cologne list
Related search terms: Absorption kinetics